Status:
UNKNOWN
Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
Lead Sponsor:
Haukeland University Hospital
Conditions:
Cushing's Syndrome
Adrenal Incidentalomas
Eligibility:
All Genders
18+ years
Brief Summary
Background: The evaluation for hypercortisolism includes an overnight 1mg dexamethasone (DXM) suppression test. An important shortcoming is the diagnostic specificity of only 80%, which is likely due ...
Eligibility Criteria
Inclusion
- Age over 18 years
- Under investigation for hypercortisolism
- Able and willing to make informed consent
Exclusion
- Use of systemic or local glucocorticoids
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01504555
Start Date
October 1 2011
End Date
September 1 2017
Last Update
September 26 2016
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland Universitetssykehus- Rusmedisinsk avdeling
Bergen, Norway, 5019
2
Haukeland Universitetssykehus- Endokrinologisk avdeling
Bergen, Norway, 5021
3
Institutt for farmakologi
Bergen, Norway, 5021
4
Haukeland University Hospital- Hormonlaboratory
Bergen, Norway, 5096